risks of glp-1 Gastrointestinal effect and adverse effects receptor agonist GLP-1 Medications: Is Ozempic the

IBS/SIBO: Migrating motor complex activity (the movement of undigested food through the intestinal tract during periods between meals) is lower in patients with IBS and SIBO when compared to healthy controls, and eradicating bacterial overgrowth may improve motility 12

But remember that losing weight gradually is less stressful to your body and will lead to sustainable weight loss

Furthermore, concurrent use with cannabidiol can lead to a buildup of a Clobazam byproduct, leading to excess sedation

Even moderate alcohol intake can blunt the fat-burning effects of both peptides

Key Insight: Roughly 0.5% of the population will develop Graves disease